Dina Masi
2017
In 2017, Dina Masi earned a total compensation of $236.1K as Chief Financial Officer and Senior Vice President at Integrated Biopharma.
Compensation breakdown
| Option Awards | $1,683 |
|---|---|
| Salary | $227,151 |
| Other | $7,269 |
| Total | $236,103 |
Masi received $227.2K in salary, accounting for 96% of the total pay in 2017.
Masi also received $1.7K in option awards and $7.3K in other compensation.
Rankings
In 2017, Dina Masi's compensation ranked 13,806th out of 14,666 executives tracked by ExecPay. In other words, Masi earned more than 5.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,806 out of 14,666 | 6th |
Division Manufacturing | 5,419 out of 5,772 | 6th |
Major group Chemicals And Allied Products | 1,950 out of 2,075 | 6th |
Industry group Drugs | 1,625 out of 1,731 | 6th |
Industry Pharmaceutical Preparations | 1,245 out of 1,333 | 7th |
Source: SEC filing on October 28, 2019.
Masi's colleagues
We found three more compensation records of executives who worked with Dina Masi at Integrated Biopharma in 2017.
News
Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
October 28, 2024
Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
October 27, 2023
Integrated Biopharma CFO Dina Masi's 2022 pay rises 12% to $300K
October 27, 2022
Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
October 27, 2021
Integrated Biopharma CFO Dina Masi's 2019 pay rises 4% to $251K
October 28, 2019